Similarly, mouse models of Lewis lung carcinoma demonstrated that TAMs were derived from CCR2 driven recruitment of Ly6Chi monocytes and blockage of CCL2 decreased tumor growth (122, 123). Here, CCR2 is linked to neoplasm.